Physician profile
Ann Eapen
NPI 1154582856
$1,612.04
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $12.88 · 2021: $121 · 2023: $525 · 2024: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666 · Honoraria: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.38 |
| Honoraria | $360.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $360.00 | 2023 | |
| Janssen Biotech, INC. | $236.30 | 2019-2024 | Imbruvica, Darzalex |
| Merck Sharp & Dohme LLC | $217.43 | 2024 | Keytruda, Lynparza |
| Exelixis INC. | $133.67 | 2020-2021 | |
| Genentech USA, INC. | $133.45 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $123.74 | 2023 | Tagrisso |
| Eisai INC. | $122.28 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $121.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.40 | 2024 | |
| Smith+Nephew, INC. | $43.16 | 2024 | Tula |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Eapen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.